133 related articles for article (PubMed ID: 29232011)
1. Autograft immune effector cells and survival in autologous peripheral blood hematopoietic stem cell transplantation.
Porrata LF
J Clin Apher; 2018 Jun; 33(3):324-330. PubMed ID: 29232011
[TBL] [Abstract][Full Text] [Related]
2. Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis.
Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Villasboas JC; Markovic SN
Leuk Res; 2019 Jun; 81():1-9. PubMed ID: 30978434
[TBL] [Abstract][Full Text] [Related]
3. Natural Killer Cells Are Key Host Immune Effector Cells Affecting Survival in Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation.
Porrata LF
Cells; 2022 Nov; 11(21):. PubMed ID: 36359863
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Infused Autograft Absolute Numbers of Immune Effector Cells on Survival Post-Autologous Stem Cell Transplantation.
Porrata LF
Cells; 2022 Jul; 11(14):. PubMed ID: 35883639
[TBL] [Abstract][Full Text] [Related]
5. Infused autograft lymphocyte-to-monocyte ratio and survival in T-cell lymphoma post-autologous peripheral blood hematopoietic stem cell transplantation.
Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Hogan WJ; Markovic SN
J Hematol Oncol; 2015 Jul; 8():80. PubMed ID: 26138828
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
7. The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.
Clausen J; Kircher B; Auberger J; Schumacher P; Ulmer H; Hetzenauer G; Wolf D; Gastl G; Nachbaur D
Biol Blood Marrow Transplant; 2010 Feb; 16(2):273-80. PubMed ID: 19857587
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of hematopoietic cells and their clinical use.
Aglietta M; Bertolini F; Carlo-Stella C; De Vincentiis A; Lanata L; Lemoli RM; Olivieri A; Siena S; Zanon P; Tura S
Haematologica; 1998 Sep; 83(9):824-48. PubMed ID: 9825579
[TBL] [Abstract][Full Text] [Related]
9. Immunologic Autograft Engineering and Survival in Non-Hodgkin Lymphoma.
Porrata LF; Burgstaler EA; Winters JL; Jacob EK; Gastineau DA; Suman VJ; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Nevala W; Markovic SN
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1017-1023. PubMed ID: 26826432
[TBL] [Abstract][Full Text] [Related]
10. Importance of early immune recovery after autologous hematopoietic cell transplantation in lymphoma patients.
Jantunen E; Varmavuo V; Pelkonen J; Valtola J
Leuk Lymphoma; 2019 Sep; 60(9):2115-2121. PubMed ID: 30843749
[TBL] [Abstract][Full Text] [Related]
11. Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation.
Kim DH; Won DI; Lee NY; Sohn SK; Suh JS; Lee KB
Biol Blood Marrow Transplant; 2006 Jul; 12(7):719-28. PubMed ID: 16785061
[TBL] [Abstract][Full Text] [Related]
12. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma.
Porrata LF; Litzow MR; Inwards DJ; Gastineau DA; Moore SB; Pineda AA; Bundy KL; Padley DJ; Persky D; Ansell SM; Micallef IN; Markovic SN
Bone Marrow Transplant; 2004 Feb; 33(3):291-8. PubMed ID: 14676784
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell count in the graft predicts relapse in patients with hematologic malignancies undergoing an HLA-matched related allogeneic peripheral blood stem cell transplant.
Rajasekar R; Lakshmi KM; George B; Viswabandya A; Thirugnanam R; Abraham A; Chandy M; Srivastava A; Mathews V
Biol Blood Marrow Transplant; 2010 Jun; 16(6):854-60. PubMed ID: 20138229
[TBL] [Abstract][Full Text] [Related]
14. Do autologous peripheral blood cell transplants provide more than hematopoietic recovery?
Kessinger A
Stem Cells; 1995 Jul; 13(4):351-4. PubMed ID: 7549893
[TBL] [Abstract][Full Text] [Related]
15. Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation.
Porrata LF; Markovic SN
Clin Exp Med; 2004 Oct; 4(2):78-85. PubMed ID: 15672944
[TBL] [Abstract][Full Text] [Related]
16. Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect.
Alyea E; Weller E; Schlossman R; Canning C; Mauch P; Ng A; Fisher D; Gribben J; Freeman A; Parikh B; Richardson P; Soiffer R; Ritz J; Anderson KC
Bone Marrow Transplant; 2003 Dec; 32(12):1145-51. PubMed ID: 14647268
[TBL] [Abstract][Full Text] [Related]
17. Autologous peripheral blood stem cell transplantation with induction of autologous graft-versus-host disease in acute myeloid leukemia.
Park J; Lee MH; Lee HR; Park SH; Lee SH; Lee KE; Lee H; Park JO; Kim K; Jung CW; Im YH; Kang WK; Ko YH; Park K
Bone Marrow Transplant; 2003 Nov; 32(9):889-95. PubMed ID: 14561989
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning.
Panse JP; Heimfeld S; Guthrie KA; Maris MB; Maloney DG; Baril BB; Little MT; Chauncey TR; Storer BE; Storb R; Sandmaier BM
Br J Haematol; 2005 Mar; 128(5):659-67. PubMed ID: 15725088
[TBL] [Abstract][Full Text] [Related]
19. Improvement of Impaired Immunological Status of Patients with Various Types of Advanced Cancers by Autologous Immune Cell Therapy.
Kamigaki T; Ibe H; Okada S; Matsuda E; Tanaka M; Oguma E; Kinoshita Y; Ogasawara S; Ono A; Makita K; Naitoh K; Goto S
Anticancer Res; 2015 Aug; 35(8):4535-43. PubMed ID: 26168498
[TBL] [Abstract][Full Text] [Related]
20. Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors.
Gazitt Y
Stem Cells; 2000; 18(6):390-8. PubMed ID: 11072026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
